{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Parkinson\u2019s disease", "food sensing", "lifespan-extension", "neurotoxicity", "tyrosine hydroxylase"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27937005", "DateCompleted": {"Year": "2017", "Month": "03", "Day": "13"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "30"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "1744-5116", "JournalIssue": {"Volume": "55", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Dec"}}, "Title": "Pharmaceutical biology", "ISOAbbreviation": "Pharm Biol"}, "ArticleTitle": "Sorbus alnifolia protects dopaminergic neurodegeneration in Caenorhabditis elegans.", "Pagination": {"StartPage": "481", "EndPage": "486", "MedlinePgn": "481-486"}, "Abstract": {"AbstractText": ["The twigs of Sorbus alnifolia (Sieb. et Zucc.) K. Koch (Rosaceae) have been used to treat neurological disorders as a traditional medicine in Korea. However, there are limited data describing the efficacy of S. alnifolia in Parkinson's disease (PD).", "This study was conducted to identify the protective effects of the methanol extracts of S. alnifolia (MESA) on the dopaminergic (DA) neurodegeneration in Caenorhabditis elegans.", "To test the neuroprotective action of MESA, viability assay was performed after 48\u2009h exposure to 1-methyl-4-phenylpyridine (MMP<sup>+</sup>) in PC12 cells and C. elegans (400\u2009\u03bcM and 2\u2009mM of MMP<sup>+</sup>, respectively). Fluorescence intensity was quantified using transgenic mutants such as BZ555 (Pdat-1::GFP) and and UA57 (Pdat-1::GFP and Pdat-1::CAT-2) to determine MESA's effects on DA neurodegeneration in C. elegans. Aggregation of \u03b1-synuclein was observed using NL5901 strain (unc-54p::\u03b1-synuclein::YFP). MESA's protective effects on the DA neuronal functions were examined by food-sensing assay. Lifespan assay was conducted to test the effects of MESA on the longevity.", "MESA restored MPP<sup>+</sup>-induced loss of viability in both PC12 cells and C. elegans (85.8% and 54.9%, respectively). In C. elegans, MESA provided protection against chemically and genetically-induced DA neurodegeneration, respectively. Moreover, food-sensing functions were increased 58.4% by MESA in the DA neuron degraded worms. MESA also prolonged the average lifespan by 25.6%. However, MESA failed to alter \u03b1-synuclein aggregation.", "These results revealed that MESA protects DA neurodegeneration and recovers diminished DA neuronal functions, thereby can be a valuable candidate for the treatment of PD."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a College of Pharmacy, Woosuk University , Jeonbuk , Republic of Korea."}], "LastName": "Cheon", "ForeName": "Se-Myeong", "Initials": "SM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "b Department of Korean Internal Medicine , Woosuk University , Jeonbuk , Republic of Korea."}], "LastName": "Jang", "ForeName": "Insoo", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "c Department of Medicine, Brody School of Medicine at East , Carolina University , Greenville , NC , USA."}], "LastName": "Lee", "ForeName": "Myon-Hee", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a College of Pharmacy, Woosuk University , Jeonbuk , Republic of Korea."}], "LastName": "Kim", "ForeName": "Dae Keun", "Initials": "DK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a College of Pharmacy, Woosuk University , Jeonbuk , Republic of Korea."}], "LastName": "Jeon", "ForeName": "Hoon", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "a College of Pharmacy, Woosuk University , Jeonbuk , Republic of Korea."}], "LastName": "Cha", "ForeName": "Dong Seok", "Initials": "DS"}], "GrantList": [{"GrantID": "R15 GM112174", "Acronym": "GM", "Agency": "NIGMS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Biol", "NlmUniqueID": "9812552", "ISSNLinking": "1388-0209"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Caenorhabditis elegans Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Aggregates"}, {"RegistryNumber": "0", "NameOfSubstance": "Solvents"}, {"RegistryNumber": "0", "NameOfSubstance": "alpha-Synuclein"}, {"RegistryNumber": "R865A5OY8J", "NameOfSubstance": "1-Methyl-4-phenylpyridinium"}, {"RegistryNumber": "Y4S76JWI15", "NameOfSubstance": "Methanol"}], "MeshHeadingList": [{"QualifierName": ["toxicity"], "DescriptorName": "1-Methyl-4-phenylpyridinium"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Animals, Genetically Modified"}, {"QualifierName": ["drug effects"], "DescriptorName": "Behavior, Animal"}, {"QualifierName": ["drug effects", "genetics", "metabolism"], "DescriptorName": "Caenorhabditis elegans"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Caenorhabditis elegans Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Cytoprotection"}, {"QualifierName": ["drug effects", "metabolism", "pathology"], "DescriptorName": "Dopaminergic Neurons"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": ["drug effects"], "DescriptorName": "Feeding Behavior"}, {"QualifierName": ["drug effects"], "DescriptorName": "Longevity"}, {"QualifierName": ["chemistry"], "DescriptorName": "Methanol"}, {"QualifierName": ["drug effects"], "DescriptorName": "Motor Activity"}, {"QualifierName": [], "DescriptorName": "Nerve Degeneration"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": [], "DescriptorName": "PC12 Cells"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plant Components, Aerial"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Protein Aggregates"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["chemistry"], "DescriptorName": "Solvents"}, {"QualifierName": ["chemistry"], "DescriptorName": "Sorbus"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "alpha-Synuclein"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bender A, Krishnan KJ, Morris CM, Taylor GA, Reeve AK, Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, et al. . 2006. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 38:515\u2013517.", "ArticleIdList": ["16604074"]}, {"Citation": "Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM.. 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson\u2019s disease. Prog Neurobiol. 65:135\u2013172.", "ArticleIdList": ["11403877"]}, {"Citation": "Braungart E, Gerlach M, Riederer P, Baumeister R, Hoener MC.. 2004. Caenorhabditis elegans MPP+ model of Parkinson\u2019s disease for high-throughput drug screenings. Neurodegener Dis. 1:175\u2013183.", "ArticleIdList": ["16908987"]}, {"Citation": "Brenner S.1974. The genetics of Caenorhabditis elegans. Genetics. 77:71\u201394.", "ArticleIdList": ["PMC1213120", "4366476"]}, {"Citation": "Butler B, Saha K, Rana T, Becker JP, Sambo D, Davari P, Goodwin JS, Khoshbouei H.. 2015. . Dopamine transporter activity is modulated by \u03b1-synuclein. J Biol Chem. 290:29542\u201329554.", "ArticleIdList": ["PMC4705954", "26442590"]}, {"Citation": "Cao S, Gelwix CC, Caldwell KA, Caldwell GA.. 2005. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J Neurosci. 25:3801\u20133812.", "ArticleIdList": ["PMC6724936", "15829632"]}, {"Citation": "Dawson TM, Dawson VL.. 2002. Neuroprotective and neurorestorative strategies for Parkinson\u2019s disease. Nat Neurosci. 5(Suppl):1058\u20131061.", "ArticleIdList": ["12403986"]}, {"Citation": "Dias V, Junn E, Mouradian MM.. 2013. The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis. 3:461\u2013491.", "ArticleIdList": ["PMC4135313", "24252804"]}, {"Citation": "Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D, et al. . 2004. Comparison of kindreds with Parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol. 55:174\u2013179.", "ArticleIdList": ["14755720"]}, {"Citation": "Gomez Arevalo G, Jorge R, Garcia S, Scipioni O, Gershanik O.. 1997. Clinical and pharmacological differences in early- versus late-onset Parkinson\u2019s disease. Mov Disord. 12:277\u2013284.", "ArticleIdList": ["9159719"]}, {"Citation": "Jadiya P, Khan A, Sammi SR, Kaur S, Mir SS, Nazir A.. 2011. Anti-Parkinsonian effects of Bacopa monnieri: insights from transgenic and pharmacological Caenorhabditis elegans models of Parkinson\u2019s disease. Biochem Biophys Res Commun. 413:605\u2013610.", "ArticleIdList": ["21925152"]}, {"Citation": "Katzen HL, Levin BE, Llabre ML.. 1998. Age of disease onset influences cognition in Parkinson's disease. J Int Neuropsychol Soc. 4:285\u2013290.", "ArticleIdList": ["9623003"]}, {"Citation": "Kook YH, Ka M, Um M.. 2011. . Neuroprotective cytokines repress PUMA induction in the 1-methyl-4-phenylpyridinium (MPP(+)) model of Parkinson\u2019s disease. Biochem Biophys Res Commun. 411:370\u2013374.", "ArticleIdList": ["21741364"]}, {"Citation": "Langston JW, Ballard P, Tetrud JW, Irwin I.. 1983. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:979\u2013980.", "ArticleIdList": ["6823561"]}, {"Citation": "Levy G.2007. The relationship of Parkinson disease with aging. Arch Neurol. 64:1242\u20131246.", "ArticleIdList": ["17846263"]}, {"Citation": "Li X, Chen W, Zhang L, Liu WB, Fei Z.. 2013. . Inhibition of store-operated calcium entry attenuates MPP(+)-induced oxidative stress via preservation of mitochondrial function in PC12 cells: involvement of Homer1a. PLoS One. 8:e83638. doi: 10.1371/journal.pone.0083638.", "ArticleIdList": ["10.1371/journal.pone.0083638", "PMC3866123", "24358303"]}, {"Citation": "Liou AK, Zhou Z, Pei W, Lim TM, Yin XM, Chen J.. 2005. BimEL up-regulation potentiates AIF translocation and cell death in response to MPTP. FASEB J. 19:1350\u20131352.", "ArticleIdList": ["15941767"]}, {"Citation": "Parker WD Jr, Parks JK.. 2005. Mitochondrial ND5 mutations in idiopathic Parkinson\u2019s disease. Biochem Biophys Res Commun. 326:667\u2013669.", "ArticleIdList": ["15596151"]}, {"Citation": "Sawin ER, Ranganathan R, Horvitz HR.. 2000. C. elegans locomotory rate is modulated by the environment through a dopaminergic pathway and by experience through a serotonergic pathway. Neuron. 26:619\u2013631.", "ArticleIdList": ["10896158"]}, {"Citation": "Schmidt E, Seifert M, Baumeister R.. 2007. Caenorhabditis elegans as a model system for Parkinson\u2019s disease. Neurodegener Dis. 4:199\u2013217.", "ArticleIdList": ["17596715"]}, {"Citation": "Schmidt N, Ferger B.. 2001. Neuroprotective effects of (+/\u2212)-kavain in the MPTP mouse model of Parkinson\u2019s disease. Synapse. 40:47\u201354.", "ArticleIdList": ["0"]}, {"Citation": "Schober A.2004. Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 318:215\u2013224.", "ArticleIdList": ["15503155"]}, {"Citation": "Takashima A, Koike T.. 1985. Relationship between dopamine content and its secretion in PC12 cells as a function of cell growth. Biochim Biophys Acta. 847:101\u2013107.", "ArticleIdList": ["2864958"]}, {"Citation": "Trimmer PA, Bennett JP Jr.. 2009. The cybrid model of sporadic Parkinson's disease. Exp Neurol. 218:320\u2013325.", "ArticleIdList": ["PMC2735256", "19328199"]}, {"Citation": "van Ham TJ, Thijssen KL, Breitling R, Hofstra RM, Plasterk RH, Nollen EA.. 2008. C. elegans model identifies genetic modifiers of alpha-synuclein inclusion formation during aging. PLoS Genet. 4:e1000027. doi: 10.1371/journal.pgen.1000027.", "ArticleIdList": ["10.1371/journal.pgen.1000027", "PMC2265412", "18369446"]}, {"Citation": "Yankner BA, Lu T, Loerch P.. 2008. The aging brain. Annu Rev Pathol. 3:41\u201366.", "ArticleIdList": ["18039130"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "12", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "3", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "9"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27937005", "NIHMS869297", "PMC5490792", "10.1080/13880209.2016.1251468"]}}], "PubmedBookArticle": []}